FasL, GM-CSF and IL-27 for Immunotherapy of Lung cancer
博士 === 國立陽明大學 === 醫學生物技術暨檢驗學系暨研究所 === 96 === Lung cancer is the most leading one among lethal human cancers around the world. Despite conventional therapies and understanding the mechanism for the molecular carcinogenesis of lung cancer, the overall 5-year survival rate is only 8–14% and has improve...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2008
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/28659935987805445420 |